Opposite effects of IFNβ on cytokine homeostasis in LPS- and T cell contact-activated human monocytes

Journal of Neuroimmunology

Volumn 146, Issue 1-2, 2004, Pages 76-83

  Molnarfi, Nicolas ^a   Gruaz, Lyssia ^a   Dayer, Jean Michel ^a   Burger, Danielle ^a  

^a University Hospital   (Switzerland)

Author keywords

Cytokines; Inflammation; Interferon ; Multiple sclerosis

Indexed keywords

BETA INTERFERON; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL COMMUNICATION; CELL LINE; CELL MEMBRANE; CELL STIMULATION; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; DOSE RESPONSE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0346101877     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.035     Document Type: Article

References (35)

1. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:1997;165-173.
2. Burger D., Dayer J.M. IL-1Ra. Oppenheim J.J., Feldmann M. Cytokine Reference. 2000;319-336 Academic Press, London.
3. Burger D., Dayer J.M. The role of human T lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res. 4(Suppl. 3):2002;S169-S176.
4. Burger D., Rezzonico R., Li J.M., Modoux C., Pierce R.A., Welgus H.G., Dayer J.M. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum. 41:1998;1748-1759.
5. Chabot S., Yong V.W. Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: relevance to MS. Neurology. 55:2000;1497-1505.
6. Chabot S., Williams G., Yong V.W. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferon beta-1b. J. Clin. Invest. 100:1997;604-612.
7. Chabot S., Charlet D., Wilson T.L., Yong V.W. Cytokine production consequent to T cell-microglia interaction: the PMA/IFN gamma-treated U937 cells display similarities to human microglia. J. Neurosci. Methods. 105:2001;111-120.
8. Dasgupta S., Jana M., Liu X., Pahan K. Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells. J. Biol. Chem. 278:2003;22424-22431.
9. Déage V., Burger D., Dayer J.M. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases. Eur. Cytokine Netw. 9:1998;663-668.
10. Dinarello C.A. IL-1alpha. Oppenheim J.J., Feldmann M. Cytokine Reference. 2000;307-318 Academic Press, London.
11. Gazdar A.F., Carney D.N., Bunn P.A., Russell E.K., Jaffe E.S., Schechter G.P., Guccion J.G. Mitogen requirements for the in vitro propagation of T-cell lymphomas. Blood. 55:1980;409-417.
12. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:1999;219-240.
13. Heesen C., Sieverding F., Buhmann C., Gbadamosi J. IL-1Ra serum levels in disease stages of MS - a marker for progression? Acta Neurol. Scand. 101:2000;95-97.
14. Hellings N., Raus J., Stinissen P. Insights into the immunopathogenesis of multiple sclerosis. Immunol. Res. 25:2002;27-51.
15. Hyka N., Dayer J.M., Modoux C., Kohno T., Edwards C.K. III, Roux-Lombard P., Burger D. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 97:2001;2381-2389.
16. Iglesias A., Bauer J., Litzenburger T., Schubart A., Linington C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia. 36:2001;220-234.
17. Jungo F., Dayer J.M., Modoux C., Hyka N., Burger D. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine. 14:2001;272-282.
18. Keegan B.M., Noseworthy J.H. Multiple sclerosis. Annu. Rev. Med. 53:2002;285-302.
19. Kunzi M.S., Rowe P.P. IFN alpha, IFN beta, and IFN omega ligands. Oppenheim J.J., Feldmann M. Cytokine Reference. 2000;627-639 Academic Press, London.
20. Liu J.S., Amaral T.D., Brosnan C.F., Lee S.C. IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia. J. Immunol. 161:1998;1989-1996.
21. Liu H., MacKenzie-Graham A.J., Palaszynski K., Liva S., Voskuhl R.R. Classic myelin basic proteins are expressed in lymphoid tissue macrophages. J. Neuroimmunol. 116:2001;83-93.
22. Maeda A., Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:1996;300-309.
23. Martin R., McFarland H.F., McFarlin D.E. Immunological aspect of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
24. Nicoletti F., Patti F., DiMarco R., Zaccone P., Nicoletti A., Meroni P., Reggio A. Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment. Cytokine. 8:1996;395-400.
25. Noronha A., Toscas A., Jensen M.A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;145-153.
26. Pahan K., Raymond J.R., Singh I. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J. Biol. Chem. 274:1999;7528-7536.
27. Perini P., Tiberio M., Sivieri S., Facchinetti A., Biasi G., Gallo P. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a. Eur. Cytokine Netw. 11:2000;81-86.
28. Raine C.S. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50:1984;608-635.
29. Rep M.H.G., Hintzen R.Q., Polman C.H., Vanlier R.A.W. Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 67:1996;111-118.
30. Rothuizen L.E., Buclin T., Spertini F., Trinchard I., Munafo A., Buchwalder P.A., Ythier A., Biollaz J. Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. J. Neuroimmunol. 99:1999;131-141.
31. Schilling D., Thomas K., Nixdorff K., Vogel S.N., Fenton M.J. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J. Immunol. 169:2002;5874-5880.
32. Sciacca F.L., Canal N., Grimaldi L.M.E. Induction of IL-1 receptor antagonist by interferon beta: implication for the treatment of multiple sclerosis. J. Neurovirol. 6:2000;S33-S37.
33. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:2002;392-398.
34. Tyor W.R., Glass J.D., Baumrind N., McArthur J.C., Griffin J.W., Becker P.S., Griffin D.E. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology. 43:1993;1002-1009.
35. Yong V.W., Chabot S., Stuve O., Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology. 51:1998;682-689.